HealthcareServices

Genome-Wide Association Studies Market Forecast 2025–2034: Where Businesses Should Invest Next

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Genome-Wide Association Studies Market By 2029?

The genome-wide association studies market has seen rapid expansion in recent years. It is anticipated to grow from $1.99 billion in 2024 to $2.27 billion in 2025, at a compound annual growth rate (CAGR) of 13.8%. This historical growth can be ascribed to the increasing incidence of chronic diseases, a heightened recognition of genetic influences in illnesses, wider adoption of genomic research, augmented government financial backing for genomics, and the expanding network of biobanks and genomic databases.

The market for genome-wide association studies is projected to experience swift expansion in the coming years. This market is anticipated to reach $3.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.5%. Factors contributing to this growth over the forecast period include the expanding application of pharmacogenomics in clinical environments, increasing embrace of multi-omics methodologies, escalating need for personalized medicine, intensified genomic research across varied populations, and the advancing creation of point-of-care genetic testing. Key trends anticipated during this period encompass technological progress in sequencing platforms, novelties in data analysis algorithms, evolution in functional genomics, ongoing research and development into gene-environment interactions, and breakthroughs in genome editing technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28234&type=smp

Which Drivers Are Shaping The Genome-Wide Association Studies Industry’s Market Share?

The increasing demand for personalized medicine is projected to drive the growth of the genome-wide association studies market. Personalized medicine represents a medical approach that customizes treatment and prevention strategies based on an individual’s unique genetic makeup, lifestyle, and environment. The rising adoption of personalized medicine is primarily attributed to advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments for individuals. Genome-wide association studies (GWAS) bolster personalized medicine by identifying genetic variations linked to diseases, thereby enabling targeted treatment approaches. These studies enhance healthcare outcomes by offering insights into individual risk profiles and supporting precision therapies. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant increase from the 12 approved in 2022. Thus, the escalating demand for personalized medicine is propelling the expansion of the genome-wide association studies market.

Which Key Segments Fueling The Genome-Wide Association Studies Market?

The genome-wide association studies market covered in this report is segmented as

1) By Product Type: Genotyping Services, Genotyping Kits And Reagents, Software And Data Analysis Tools, Other Product Types

2) By Application: Drug Discovery, Disease Risk Assessment, Personalized Medicine, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Genotyping Services: Whole Genome Sequencing (Wgs), Exome Sequencing, Targeted Genotyping

2) By Genotyping Kits And Reagents: Dna Extraction Kits, Sequencing Reagents, Library Preparation Kits

3) By Software And Data Analysis Tools: Bioinformatics Platforms, Data Visualization Tools, Statistical Analysis Software

4) By Other Product Types: Sample Collection Devices, Quality Control Tools, Laboratory Consumables

Which Trends Are Impacting The Genome-Wide Association Studies Market?

Leading companies operating within the genome-wide association studies market are concentrating on developing innovative solutions, such as sophisticated research platforms, to accelerate the discovery of diseases and advance personalized medicine applications. An advanced research platform is an integrated system comprising tools and technologies that enable large-scale genomic data generation, analysis, and interpretation for genome-wide association studies. For instance, in January 2025, 23andMe Holding Co., a US-based biotechnology company, launched Discover23, a consumer-focused platform for genetic insights and ancestry exploration. This platform allows biopharma collaborators to access comprehensive genetic data through a trusted environment powered by Lifebit. It provides analysis-ready genome-wide association studies (GWAS) for over 1,000 disease cohorts, which are derived from billions of phenotypic data points from millions of consenting participants. The advanced research platform aims to accelerate drug discovery by assisting researchers in identifying novel disease biology and potential drug targets, thereby improving clinical trial success while consistently maintaining participant privacy.

Which Key Players Are Driving Competition In The Genome-Wide Association Studies Market?

Major companies operating in the genome-wide association studies market are F. Hoffmann-La Roche AG, AstraZeneca plc, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Laboratory Corporation of America Holdings, Daiichi Sankyo Company Limited, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Databricks Inc., Broad Institute of MIT and Harvard, BGI Genomics Co. Ltd., deCODE genetics Inc., Genomics England Ltd., CD Genomics Inc., Veritas Genetics Inc., Finngen, and The Wellcome Sanger Institute.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genome-wide-association-studies-global-market-report

How Do Regional Market Performances Compare Within The Genome-Wide Association Studies Industry?

North America was the largest region in the genome-wide association studies market in 2024. The regions covered in genome-wide association studies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Genome-Wide Association Studies Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28234&type=smp

Browse Through More Reports Similar to the Global Genome-Wide Association Studies Market 2025, By The Business Research Company

Genomic Data Analysis And Interpretation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomic-data-analysis-and-interpretation-global-market-report

Genomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genomics Personalized Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795